Initiative calls for more research and improved treatment methods on musculoskeletal pain

INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAINOct 19 2009

The Global Year Against Musculoskeletal Pain launches today, focusing attention on one of the largest and most significant areas of pain. Sponsored by the nonprofit International Association for the Study of Pain (IASP), the 12-month campaign aims to generate greater awareness among medical researchers, health professionals, government leaders, and the general public about musculoskeletal pain and its substantial global impact.

More people worldwide experience musculoskeletal pain than any other category of pain. According to experts, the problem is complex and far-reaching, encompassing many different types of pain, including neck pain, joint pain, low back pain, bone pain, and chronic widespread pain. Despite the range of conditions and symptoms involved, all types of musculoskeletal pain share similar underlying mechanisms, manifestations, and potential treatments.

With its theme of "When Moving Hurts: Assess, Understand, Take Action," the Global Year Against Musculoskeletal Pain provides a platform for people - especially pain researchers and clinicians - to explore these issues and develop more effective treatment methods to relieve pain and suffering. Led by Global Year Co-Chairs Dr. Lars Arendt-Nielsen (Denmark) and Dr. Kathleen Sluka (United States), the campaign is mobilizing IASP members and chapters worldwide to sponsor symposia, pain camps, publications, interviews, and other efforts to raise the profile of musculoskeletal pain. IASP is also providing free fact sheets on its website covering more than 20 topics related to this category of pain.

"I urge everyone who is concerned about pain - from researchers and health care professionals to government and community leaders - to join us in this vital effort as we confront the challenges of musculoskeletal pain in all its forms," said IASP President G.F. Gebhart. "By working together and sharing the latest research and treatment approaches, we can greatly reduce pain and suffering in millions of patients around the world."